CHM 6.25% 1.7¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-37

  1. 7,859 Posts.
    lightbulb Created with Sketch. 3352
    Save you the hassle, Dalts.... this from their website (not sure of the publication date):-


    https://hotcopper.com.au/data/attachments/6026/6026304-b741aead516ed33d6b40885e2ff6bb0c.jpg



    The other solid tumors in pre-clinical development are melanoma, colorectal and prostate cancers.... in both CTX Car-T and Car-NK cell therapies. So, potentially way beyond GBM and into bigger markets.

    Last edited by Shellbell: 12/03/24
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
0.001(6.25%)
Mkt cap ! $15.07M
Open High Low Value Volume
1.7¢ 1.9¢ 1.7¢ $45.06K 2.512M

Buyers (Bids)

No. Vol. Price($)
1 62187 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 200000 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.